Free Trial

ResMed (RMD) Short Interest Ratio & Short Volume

ResMed logo
$231.61 -1.18 (-0.51%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$231.56 -0.05 (-0.02%)
As of 02/21/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ResMed Short Interest Data

ResMed (RMD) has a short interest of 8.30 million shares. This marks a 3.23% increase in short interest from the previous month. The short interest ratio (days to cover) is 9.6, indicating that it would take 9.6 days of the average trading volume of 955,284 shares to cover all short positions.

Current Short Interest
8,300,000 shares
Previous Short Interest
8,040,000 shares
Change Vs. Previous Month
+3.23%
Dollar Volume Sold Short
$1.96 billion
Short Interest Ratio
9.6 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
146,870,000 shares
Percentage of Shares Shorted
5.65%
Today's Trading Volume
518,460 shares
Average Trading Volume
955,284 shares
Today's Volume Vs. Average
54%
Short Selling ResMed?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for ResMed and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RMD Short Interest Over Time

RMD Days to Cover Over Time

RMD Percentage of Float Shorted Over Time

ResMed Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20258,300,000 shares $1.96 billion +3.2%N/A9.6 $236.66
1/15/20258,040,000 shares $1.87 billion +1.6%N/A8.9 $233.01
12/31/20247,910,000 shares $1.81 billion +1.3%N/A8.9 $228.69
12/15/20247,810,000 shares $1.86 billion +3.6%N/A8.3 $238.52
11/30/20247,540,000 shares $1.88 billion +3.2%N/A7.8 $249.02
11/15/20247,310,000 shares $1.72 billion -7.4%N/A7.1 $234.77
10/31/20247,890,000 shares $1.91 billion -8.9%N/A7.7 $242.47
10/15/20248,660,000 shares $2.07 billion +1.1%N/A8.5 $239.18
9/30/20248,570,000 shares $2.09 billion -0.1%N/A8.6 $244.13
9/15/20248,580,000 shares $2.14 billion +0.4%N/A7.9 $248.93
8/31/20248,550,000 shares $2.09 billion -12.6%N/A7.9 $245.02
8/15/20249,780,000 shares $2.22 billion +9.9%N/A9.1 $227.26
7/31/20248,900,000 shares $1.90 billion +5.0%N/A8.4 $213.25
7/15/20248,480,000 shares $1.74 billion -1.2%N/A7.9 $205.31
6/30/20248,580,000 shares $1.64 billion +4.1%N/A7.6 $191.42
6/15/20248,240,000 shares $1.74 billion -16.5%N/A7.3 $211.73
5/31/20249,870,000 shares $2.04 billion -3.3%N/A9.2 $206.33
5/15/202410,210,000 shares $2.25 billion +3.7%N/A9.5 $220.63
4/30/20249,850,000 shares $2.11 billion +23.9%N/A9 $214.04
4/15/20247,950,000 shares $1.47 billion +0.8%N/A7.5 $185.09
3/31/20247,890,000 shares $1.56 billion +3.0%N/A7.8 $198.03
3/15/20247,660,000 shares $1.46 billion +13.3%N/A7.9 $190.10
2/29/20246,760,000 shares $1.17 billion +2.7%N/A7.4 $173.72
2/15/20246,580,000 shares $1.20 billion +4.0%N/A7.4 $182.64
1/31/20246,330,000 shares $1.20 billion +7.5%N/A6.5 $190.20
1/15/20245,890,000 shares $1.02 billion +3.9%N/A5.5 $173.90
12/31/20235,670,000 shares $975.35 million -2.4%N/A4.8 $172.02
12/15/20235,810,000 shares $982.18 million -0.7%N/A4.4 $169.05
11/30/20235,850,000 shares $922.72 million -7.3%N/A3.9 $157.73
11/15/20236,310,000 shares $960.07 million +10.3%N/A3.9 $152.15
10/31/20235,720,000 shares $807.78 million +18.4%N/A3.3 $141.22
10/15/20234,830,000 shares $677.41 million +1.5%N/A2.9 $140.25
9/30/20234,760,000 shares $703.86 million +24.6%N/A3.2 $147.87
9/15/20233,820,000 shares $555.39 million +20.9%N/A2.9 $145.39
8/31/20233,160,000 shares $504.30 million +110.7%N/A2.8 $159.59
8/15/20231,500,000 shares $275.03 million +19.1%N/A1.6 $183.35
7/31/20231,260,000 shares $280.16 million -5.3%N/A1.7 $222.35
7/15/20231,330,000 shares $295.73 million +11.8%N/A2.1 $222.35
6/30/20231,190,000 shares $260.02 million +15.5%N/A1.9 $218.50
6/15/20231,030,000 shares $225.42 million -28.5%N/A1.7 $218.85
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
5/31/20231,440,000 shares $303.54 million +38.5%N/A2.4 $210.79
5/15/20231,040,000 shares $241.79 million +2.0%N/A1.9 $232.49
4/30/20231,020,000 shares $245.78 million -11.3%N/A1.8 $240.96
4/15/20231,150,000 shares $258.24 million -19.0%N/A2 $224.56
3/31/20231,420,000 shares $310.97 million +9.2%1.0%2.3 $218.99
3/15/20231,300,000 shares $270.39 million +20.4%0.9%2 $207.99
2/28/20231,080,000 shares $230.04 million +1.9%0.7%1.7 $213.00
2/15/20231,060,000 shares $227.77 million +25.5%0.7%1.7 $214.88
1/31/2023844,900 shares $192.95 million -0.6%0.6%1.5 $228.37
1/15/2023850,000 shares $185.39 million -15.8%0.6%1.5 $218.10
12/30/20221,010,000 shares $210.21 million +6.3%0.7%1.8 $208.13
12/15/2022950,100 shares $204.31 million -5.9%0.7%1.8 $215.04
11/30/20221,010,000 shares $232.50 million -5.6%0.7%2 $230.20
11/15/20221,070,000 shares $239.28 million -18.3%0.7%2.2 $223.63
10/31/20221,310,000 shares $293.03 million +6.5%0.9%2.6 $223.69
10/15/20221,230,000 shares $260.45 million -8.2%0.9%2.6 $211.75
9/30/20221,340,000 shares $292.52 million -11.3%0.9%2.9 $218.30
9/15/20221,510,000 shares $341.18 million +18.0%1.0%3 $225.95
8/31/20221,280,000 shares $281.50 million -3.0%0.9%2.3 $219.92
8/15/20221,320,000 shares $312.99 million -28.3%0.9%2.4 $237.11
7/31/20221,840,000 shares $442.56 million +18.7%1.3%3.2 $240.52
7/15/20221,550,000 shares $349.53 million +11.5%1.1%2.5 $225.50
6/30/20221,390,000 shares $291.39 million -7.3%1.0%2.3 $209.63
6/15/20221,500,000 shares $304.92 million +15.4%1.0%2.5 $203.28
5/31/20221,300,000 shares $264.50 million -4.4%0.9%2.4 $203.46
5/15/20221,360,000 shares $267.73 million +5.4%0.9%2.4 $196.86
4/30/20221,290,000 shares $257.96 million -1.5%0.9%2.2 $199.97
4/15/20221,310,000 shares $306.82 million +6.5%0.9%2.2 $234.21
3/31/20221,230,000 shares $298.29 million +27.8%0.9%2 $242.51
3/15/2022962,200 shares $235.08 million -16.3%0.7%1.7 $244.31
2/28/20221,150,000 shares $283.76 million -8.0%0.8%2 $246.75
2/15/20221,250,000 shares $294.06 million +44.3%0.9%2.2 $235.25
1/31/2022866,400 shares $198.06 million +9.7%0.6%1.6 $228.60
1/15/2022790,100 shares $199.23 million +3.6%0.6%1.6 $252.16
12/31/2021762,800 shares $198.69 million +3.2%0.5%1.5 $260.48
12/15/2021739,000 shares $189.60 million -13.1%0.5%1.3 $256.56
11/30/2021850,600 shares $216.78 million -8.0%0.6%1.5 $254.85
11/15/2021924,400 shares $242.53 million -11.1%0.6%1.7 $262.37
10/29/20211,040,000 shares $273.43 million +8.8%0.7%2 $262.91
10/15/2021955,600 shares $244.15 million -2.5%0.7%1.9 $255.49
9/30/2021979,800 shares $258.23 million -10.1%0.7%2.1 $263.55
9/15/20211,090,000 shares $316.56 million No Change0.8%2.3 $290.42
8/31/20211,090,000 shares $316.68 million -11.4%0.8%2.1 $290.53
8/13/20211,230,000 shares $338.37 million +16.0%0.9%2.2 $275.10
7/30/20211,060,000 shares $288.11 million No Change0.7%1.8 $271.80
7/15/20211,060,000 shares $264.58 million -10.2%0.7%1.7 $249.60
6/30/20211,180,000 shares $290.89 million -16.3%0.8%1.9 $246.52
6/15/20211,410,000 shares $333.41 million -0.7%1.0%2.2 $236.46
5/28/20211,420,000 shares $292.31 million -9.0%1.0%2.4 $205.85
5/14/20211,560,000 shares $303.98 million +40.5%N/A2.5 $194.86
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
4/30/20211,110,000 shares $230.78 million -2.6%N/A1.6 $207.91
4/15/20211,140,000 shares $236.76 million +17.2%N/A1.7 $207.68
3/31/2021972,500 shares $184.10 million +5.6%N/A1.5 $189.31
3/15/2021920,600 shares $170.42 million -9.8%N/A1.4 $185.12
2/26/20211,020,000 shares $198.88 million -14.3%N/A1.7 $194.98
2/12/20211,190,000 shares $238.63 million +9.2%N/A2.1 $200.53
1/29/20211,090,000 shares $235.36 million +0.9%N/A2.1 $215.93
1/15/20211,080,000 shares $230.34 million No ChangeN/A2.3 $213.28
12/31/20201,080,000 shares $226.50 million -4.4%N/A2.3 $209.72
12/15/20201,130,000 shares $233.21 million -3.4%N/A2.3 $206.38
11/30/20201,170,000 shares $245.28 million -20.4%N/A2.3 $209.64
11/15/20201,470,000 shares $315.67 million +9.7%N/A2.9 $214.74
10/30/20201,340,000 shares $240.54 million -8.8%N/A2.4 $179.51
10/15/20201,470,000 shares $261.38 million -3.3%N/A2.5 $177.81
9/30/20201,520,000 shares $260.57 million +2.7%N/A2.6 $171.43
9/15/20201,480,000 shares $259.81 million -11.4%N/A2.4 $175.55
8/31/20201,670,000 shares $301.90 million +3.7%N/A2.5 $180.78
8/14/20201,610,000 shares $284.62 million -9.0%N/A2.3 $176.78
7/31/20201,770,000 shares $358.44 million +0.6%N/A2.6 $202.51
7/15/20201,760,000 shares $343.27 million -18.1%N/A2.6 $195.04
6/30/20202,150,000 shares $412.80 million +54.7%N/A3.1 $192.00
6/15/20201,390,000 shares $223.36 million -18.2%N/A1.9 $160.69
5/29/20201,700,000 shares $273.39 million -11.0%N/A2 $160.82
5/15/20201,910,000 shares $313.47 million +22.4%N/A2.2 $164.12
4/30/20201,560,000 shares $242.30 million -14.3%N/A1.8 $155.32
4/15/20201,820,000 shares $291.51 million +6.4%1.3%2.2 $160.17
3/31/20201,710,000 shares $275.31 million -8.6%1.2%2.1 $161.00
3/13/20201,871,400 shares $299.09 million -16.5%N/A3.4 $159.82
2/28/20202,240,000 shares $271.85 million -5.5%1.6%4.1 $121.36

RMD Short Interest - Frequently Asked Questions

What is ResMed's current short interest?

Short interest is the volume of ResMed shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 8,300,000 shares of RMD short. Learn More on ResMed's current short interest.

What is a good short interest ratio for ResMed?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RMD shares currently have a short interest ratio of 10.0. Learn More on ResMed's short interest ratio.

Which institutional investors are shorting ResMed?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ResMed: GTS Securities LLC, CSS LLC IL, Wolverine Trading LLC, Squarepoint Ops LLC, Select Equity Group L.P., Point72 Asset Management L.P., Millennium Management LLC, Group One Trading LLC, Cubist Systematic Strategies LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Jane Street Group LLC, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, JPMorgan Chase & Co., Twin Tree Management LP, Hestia Capital Management LLC, and Baader Bank Aktiengesellschaft. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is ResMed's short interest increasing or decreasing?

ResMed saw a increase in short interest during the month of January. As of January 31st, there was short interest totaling 8,300,000 shares, an increase of 3.2% from the previous total of 8,040,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does ResMed's short interest compare to its competitors?

Here is how the short interest of companies compare to ResMed: Medtronic plc (1.10%), Becton, Dickinson and Company (0.94%), Edwards Lifesciences Co. (1.74%), IDEXX Laboratories, Inc. (2.42%), DexCom, Inc. (2.52%), STERIS plc (1.02%), Insulet Co. (3.48%), Baxter International Inc. (3.42%), Hologic, Inc. (2.69%), Globus Medical, Inc. (1.60%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short ResMed stock?

Short selling RMD is an investing strategy that aims to generate trading profit from ResMed as its price is falling. RMD shares are trading down $1.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ResMed?

A short squeeze for ResMed occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RMD, which in turn drives the price of the stock up even further.

How often is ResMed's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RMD, twice per month. The most recent reporting period available is January, 31 2025.




This page (NYSE:RMD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners